The Schreiber Research Group team members provide training and are able to develop training materials on a range of topics related to addiction-prone substances.
The Benzodiazepine Action Work Group of the Colorado Consortium for Prescription Drug Abuse Preventionhosts a screening of Medicating Normal followed by a post-screening panel discussion/Q&A. The mission of the Benzodiazepine Action Work Group is to increase benzodiazepine safety through education, patient support, and informed prescribing and deprescribing practices. The group joined the Consortium in November 2020.
On October 28, 2020, I participated in the Microsoft AlumniHero Ask Us Anything Event. I had the privilege of appearing with other AlumniHero’s who are doing amazing work in their communities and throughout the world. During the event, I had the opportunity to discuss the work of The Schreiber Research Group, running a nonprofit, and giving back to the community.